Login / Signup

ESCRT-I fuels lysosomal degradation to restrict TFEB/TFE3 signaling via the Rag-mTORC1 pathway.

Marta KaczmarekJarosław CendrowskiEwelina SzymańskaMalwina Grębowicz-MaciukiewiczNoga Budick-HarmelinMatylda MaciasAleksandra SzybińskaMichał MazurKrzysztof KolmusKrzysztof GorycaMichalina DąbrowskaAgnieszka PaziewskaMichał MikulaMarta Miaczynska
Published in: Life science alliance (2022)
Within the endolysosomal pathway in mammalian cells, ESCRT complexes facilitate degradation of proteins residing in endosomal membranes. Here, we show that mammalian ESCRT-I restricts the size of lysosomes and promotes degradation of proteins from lysosomal membranes, including MCOLN1, a Ca 2+ channel protein. The altered lysosome morphology upon ESCRT-I depletion coincided with elevated expression of genes annotated to biogenesis of lysosomes due to prolonged activation of TFEB/TFE3 transcription factors. Lack of ESCRT-I also induced transcription of cholesterol biosynthesis genes, in response to inefficient delivery of cholesterol from endolysosomal compartments. Among factors that could possibly activate TFEB/TFE3 signaling upon ESCRT-I deficiency, we excluded lysosomal cholesterol accumulation and Ca 2+ -mediated dephosphorylation of TFEB/TFE3. However, we discovered that this activation occurs due to the inhibition of Rag GTPase-dependent mTORC1 pathway that specifically reduced phosphorylation of TFEB at S112. Constitutive activation of the Rag GTPase complex in cells lacking ESCRT-I restored S112 phosphorylation and prevented TFEB/TFE3 activation. Our results indicate that ESCRT-I deficiency evokes a homeostatic response to counteract lysosomal nutrient starvation, that is, improper supply of nutrients derived from lysosomal degradation.
Keyphrases
  • transcription factor
  • genome wide
  • induced apoptosis
  • poor prognosis
  • protein kinase
  • gene expression
  • heavy metals
  • risk assessment
  • replacement therapy
  • small molecule
  • endoplasmic reticulum stress
  • high glucose